Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study

被引：0
|
作者：
Yamini Pathak
Amaresh Mishra
Gourav Choudhir
Anuj Kumar
Vishwas Tripathi
机构：
[1] Gautam Buddha University,School of Biotechnology
[2] Ch. Charan Singh University,Department of Botany
[3] Uttarakhand Council for Biotechnology (UCB),Bioinformatics Laboratory
[4] Uttarakhand Council for Biotechnology (UCB),Advanced Centre for Computational and Applied Biotechnology
来源：
Pharmacological Reports | 2021年 / 73卷
关键词：
COVID-19; Cytokine storm; Drug repurposing; Main protease M; Molecular docking; Molecular dynamics simulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：926 / 938
页数：12
相关论文
共 50 条
  • [41] Pan-selectin inhibitors as potential therapeutics for COVID-19 treatment: in silico screening study
    Smak, Pavel
    Chandrabose, Selvaraj
    Tvaroska, Igor
    Koca, Jaroslav
    GLYCOBIOLOGY, 2021, 31 (08) : 975 - 987
  • [42] Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19
    AlAjmi, Mohamed F.
    Azhar, Asim
    Owais, Mohd
    Rashid, Summya
    Hasan, Sadaf
    Hussain, Afzal
    Rehman, Md Tabish
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (17): : 6676 - 6688
  • [43] Potential COVID-19 Drug from Natural Phenolic Compounds through In Silico Virtual Screening Approach
    Rathinavel, Thirumalaisamy
    Meganathan, Bhuvaneswari
    Kumarasamy, Suresh
    Ammashi, Subramanian
    Thangaswamy, Selvankumar
    Ragunathan, Yuvarajan
    Palanisamy, Srinivasan
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2021, 11 (03): : 10161 - 10173
  • [44] Indole alkaloids as potential candidates against COVID-19: an in silico study
    Mohseni, Mehran
    Bahrami, Hamed
    Farajmand, Bahman
    Hosseini, Faezeh Sadat
    Amanlou, Massoud
    Salehabadi, Hafezeh
    JOURNAL OF MOLECULAR MODELING, 2022, 28 (06)
  • [45] Indole alkaloids as potential candidates against COVID-19: an in silico study
    Mehran Mohseni
    Hamed Bahrami
    Bahman Farajmand
    Faezeh Sadat Hosseini
    Massoud Amanlou
    Hafezeh Salehabadi
    Journal of Molecular Modeling, 2022, 28
  • [46] In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
    Russo, Giulia
    Pennisi, Marzio
    Fichera, Epifanio
    Motta, Santo
    Raciti, Giuseppina
    Viceconti, Marco
    Pappalardo, Francesco
    BMC BIOINFORMATICS, 2020, 21 (Suppl 17)
  • [47] In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform
    Giulia Russo
    Marzio Pennisi
    Epifanio Fichera
    Santo Motta
    Giuseppina Raciti
    Marco Viceconti
    Francesco Pappalardo
    BMC Bioinformatics, 21
  • [48] Potential Adverse Drug Reactions of Chloroquine in the Treatment of COVID-19
    Wang, Guangfei
    Ye, Qiaofeng
    Huang, Yidie
    Lu, Jinmiao
    Zhu, Yiqing
    Zhu, Lin
    Li, Xiaoxia
    Zhang, Junqi
    Li, Ziwei
    Lan, Jianger
    Li, Zhiping
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2020, 22 (11)
  • [49] Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment
    Wang, Amy Q. Q.
    Hagen, Natalie R. R.
    Padilha, Elias C. C.
    Yang, Mengbi
    Shah, Pranav
    Chen, Catherine Z. Z.
    Huang, Wenwei
    Terse, Pramod
    Sanderson, Philip
    Zheng, Wei
    Xu, Xin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [50] Flavonoids as potential agents for development of multi-target drugs for covid-19 treatment: An in silico study
    Nguyen Thu Hang
    Nguyen Van Phuong
    VIETNAM JOURNAL OF CHEMISTRY, 2022, 60 (03) : 281 - 296
12345